PRE-MARKET | October 07, 2016 | $EXEL, $AMZN, $GS, $FSLR, $HON, $DB, $TOT, $TWTR

by Alpha | Oct 7, 2016 | Pre-Market

PRE-MARKET MOVERS

1. LPCN: $LPCN H.C. Wainwright Starts Lipocine Inc at Buy, PT $25

2. GPS:  $GPS Gap Climbs After September Sales Decline Isn’t as Bad as Feared – BBG

3. RUN:  $RUN Goldman Sachs Upgrades Sunrun to Buy, $10 PT

4. CIT:  $CIT Avolon Holdings to buy CIT Group’s aircraft leasing unit for $10 billion – Reuters

5. INCY:  $INCY Incyte Issues Updates on Epacadostat + Keytruda Phase 1; Says Median PFS Not Reached – SI

6. GWPH:  $GWPH Goldman Sachs Sees 42% Upside in GW Pharma and Initiates Coverage at ‘Buy’, $189 PT

7. ZYNE:  $ZYNE H.C. Wainwright Starts Zynerba Pharmaceuticals at Buy, $22 PT

8. SIMO:  $SIMO Silicon Motion’s stock surges after revenue outlook raised – MarketWatch

9. EXEL:  $EXEL Exelixis Announces Phase 1 Trial Results for Cabozantinib – Business Wire

10. RL:  $RL Goldman Sachs Adds Ralph Lauren to Conviction Buy List, $120 PT

11. COLM:  $COLM Goldman Sachs Adds Columbia Sportswear to Conviction Buy List

12. DVAX:  $DVAX Steven Cohen reports 5.9 pct passive stake in Dynavax Technologies Corp – Reuters

13. TOT:  $TOT Total Sells Chemical Unit Atotech to Carlyle for $3.2 Billion – WSJ

14. AMZN:  $AMZN Amazon Looms Quietly in Digital Ad Landscape – WSJ

18. DB: $DB Deutsche Bank Said to Be Exploring Capital Options – BBG

19. DB:  $DB Qatar won’t sell Deutsche Bank shares, might buy more – sources – Reuters

20. VOD:  $VOD Vodafone acquires Indian spectrum for $3 billion – MarketWatch

21. HELE:  $HELE Helen of Troy cuts annual sales outlook – MArketWatch

22. VZ, YHOO:  $YHOO Verizon $VZ wants $1B discount on Yahoo deal after reports of hacking, spying – NYPost

23. FSLR:  $FSLR Goldman Sachs Downgrades First Solar to Neutral, $42 PT

24. RT:  $RT Ruby Tuesday Q1 Sales Decline, Closes 95 Stores In Quarter – benzinga

25. AXGN:  $AXGN Axogen announces proposed public offering of common stock – Reuters

26. TSN:  $TSN Pivotal Research Cuts Tyson to Sell with Price Target of $40

27. MACK:  $MACK JPMorgan Downgrades Merrimack Pharmaceuticals to Neutral, $7 PT

28. MG:  $MG Mistras Group, Inc. Tops Q1 EPS by 2c, Lowers FY17 Guidance – Street Insider

29. SEDG:  $SEDG Goldman Sachs Downgrades SolarEdge Technologies to Sell, $13 PT

30. HON:  $HON Honeywell cuts sales projections on slowdown – MarketWatch

31. ACIA:  $ACIA Acacia Communications Announces Pricing of Follow-On Public Offering – GlobeNewswire

32. CDTX:  $CDTX Cidara Therapeutics Announces Commencement of Public Offering of Common Stock Read more:

UPGRADES

DOWNGRADES

Trending Social Alerts

1. GWPH:Goldman upgrades SMID biotech to attractive. $GWPH initiated buy at GS with $189/target

2. CLVS:$CLVS down 8% –> Rucaparib 0% ORR for platinum-refractory patients, 25% ORR for platinum-resistant patients

3. SCYX:$SCYX upgraded to Strong Buy at WBB Securities.

4. CDTX:$CDTX Cidara Therapeutics Announces Commencement of Public Offering of Common Stock Read more:

5. RL:$RL Goldman Sachs Adds Ralph Lauren to Conviction Buy List, $120 PT

6. INCY:$INCY – epacadostat + Keytruda in melanoma PFS rate of 74% at 6 mos., 57% at 12 mos. mPFS not yet reached. Median follow up 56 wks. #ESMO17

7. ABUS:$ABUS CMO and Managing Directors AXED after embarrassing trial results last week: cc: @egomaniakos

8. ALNY:MS $ALNY Revusiran Discontinuation Raises Key Questions; Downgrading PT $36.00 Imbalance of mortality leads

9. SAGE:@tgtxdough Renewed interest in CNS disorders has created a rich pipeline of new candidates Names recommend $AVXS $GWPH $SAGE

10. KITE:@tgtxdough Immuno-oncology continues to emerge as a cornerstone of cancer treatment. Names recommend $INCY $KITE

Trending News Headlines

1. Andy Biotech on Twitter

“$CLVS down 8% –> Rucaparib 0% ORR for platinum-refractory patients, 25% ORR for platinum-resistant patients”

2. Clovis Oncology Presents Efficacy and Safety Data from New Drug Application (NDA) Population for Rucaparib in the Treatment of Advanced Mutant BRCA Ovarian Cancer at 2016 ESMO Congress | Business Wire

Clovis Oncology (NASDAQ:CLVS) announced today the oral presentation of the primary efficacy and safety data from its NDA dataset for rucaparib at

3. Liquid Biopsy on Twitter

“$INCY $MRK #ESMO16 Update – Thoughts on ECHO-202/KEYNOTE-037 Initial melanoma PFS trend look competitive vs. (cont)

4. Payrolls in U.S. Rise 156,000 as Americans Stream Into Workforce

Employers continued to add to payrolls in September as record openings drew more Americans into the workforce and most found jobs, indicating the U.S. labor market is settling into a pace that will support the economy.

5. Data Presented at ESMO 2016 Adds to Understanding of Abraxane® as a Therapy for Patients with Historically Challenging Solid Tumors (NASDAQ:CELG)

Multiple presentations evaluate ABRAXANE alone or in combination with novel agents and novel regimens to treat mPAC, NSCLC, and MBC SUMMIT, N.J.–(BUSINESS WIRE)– …

6. Bridge and Tunnel Investor

Visit our forum at: bridgeandtunnelinvestor.com

7. Ruby Tuesday, Inc. (NYSE:RT) – Ruby Tuesday Q1 Sales Decline, Closes 95 Stores In Quarter

Shares of Ruby Tuesday, Inc. (NYSE: RT) are down following the release of its Q1 earnings after Thursday’s market close. The restaurant operator’s total revenue…

Technology News

PRE-MARKET | October 05, 2016 | $NFLX, $TMH, $ACIA, $TWTR, $UBS, $SPY, $GDX

by Alpha | Oct 5, 2016 | Pre-Market

PRE-MARKET MOVERS

1. CPRX:  $CPRX Piper Jaffray Upgrades Catalyst Pharmaceutical Partners to Overweight, $4 PT

2. ACIA:  $ACIA Acacia Hikes Q3 Earnings Guidance Again After Stock Passes Key Test – IBD

3. CRBP:  $CRBP Cantor Fitzgerald Starts Corbus Pharmaceuticals at Buy, $17 PT

4. ONVO:  $ONVO Organovo Announces Plans to Develop 3D Bioprinted Human Liver for Direct Transplant – SI

5. ENH:  $ENH Japan’s Sompo to Buy Insurer Endurance Specialty for $6.3 Billion – WSJ

6. TWTR:  $TWTR Twitter Is Expected to Field Bids This Week – WSJ

7. STZ:  $STZ Beer and wine maker Constellation Brands reports improved Q2 earnings, sales – MW

8. ANGO:  $ANGO AngioDynamics profit lifted by Cook Medical recall – MarketWatch

9. WUBA:  $WUBA Deutsche Bank Starts Inc at Buy, $65 PT

10. FLEX:  $FLEX Goldman Sachs Adds Flextronics to Conviction Buy List, $16 PT

11. UBS:  $UBS RBC Capital Upgrades UBS AG to Sector Perform, CHF 14 PT

12. NFLX:  $NFLX Loop Capital Begins Coverage on Netflix Inc. at BUY, $125 PT

13. MON:  $MON Monsanto Tops Q4 EPS by 9c – Street Insider

14. BUD:  $BUD Anheuser Busch Inbev SA is Resumed by Morgan Stanley to Overweight, 135EU PT

15. ADS: $ADS Atlantic Equities Starts Alliance Data Systems at Overweight, $270 PT

20. NCLH:  $NCLH UBS Cuts Norwegian Cruise Line Holdings to Neutral and Lowers Estimates, $42 PT

21. IDCC:  $IDCC Dougherty & Co Downgrades InterDigital Inc. to Neutral

22. MU:  $MU Micron Technology Warns of Tight Memory-Chip Supplies – WSJ

23. AZZ:  $AZZ Azz Inc Q2 EPS $0.38 – Reuters

24. CASC:  $CASC Cascadian Therapeutics Announces Proposal for Reverse Stock Split – GlobeNewswire

25. CRM:  $CRM Salesforce CEO Marc Benioff thinks Twitter is an ‘unpolished jewel’ that he might want to buy – BI

26. AYI: $AYI Acuity Brands Releases Earnings Results, Misses Expectations By $-0.18 EPS – Market Digest

UPGRADES

DOWNGRADES

EARNINGS

Trending Social Alerts

1. MON:#BREAKING: Monsanto $MON Q4 Revenue, $2.56B vs. $2.38B expected

2. ONVO:$ONVO Organovo Announces Plans to Develop 3D Bioprinted Human Liver for Direct Transplant – SI

3. ACIA:$ACIA Acacia Hikes Q3 Earnings Guidance Again After Stock Passes Key Test – IBD

4. REN:Rodman & Renshaw Starts Resolute Energy $REN at Buy

5. NFLX:$NFLX Loop Capital Begins Coverage on Netflix Inc. at BUY, $125 PT

Trending News Headlines

“@BioTerp JEFF agrees with your $MDGN report. Slide on $MDGN upside scenarios”

Goldman Sachs Group Inc. has sounded a warning about the outlook for China’s property market, saying that it sees growing risks across the industry and that any downturn will pose a challenge for metals, especially iron ore and steel.

McDonald’s Corp (MCD.N) is nearing a deal to sell 20-year franchise rights for its Singapore and Malaysia outlets to Saudi Arabia’s Reza group, in a transaction estimated at up to $400 million, people familiar with the matter said.

Twitter is expected to field bids this week, in a sign the long-awaited sale of the social-media pioneer could soon be at hand.

A year after his return as CEO, live-streaming and new products haven’t revived growth.

U.S. private employers added 154,000 jobs in September, below economists’ expectations, a report by a payrolls processor showed on Wednesday.

Jefferies analyst Brian Tanquilut weighed in on Team Health (NYSE: TMH) following reports Tuesday the company is in discussions with private equity sponsors to potentially take the company private….

Wall Street’s top cop is scrutinizing whether the founder of LendingClub Corp. advocated for the company to prop up its shares without telling the board about a possible conflict of interest, according to people with knowledge of the matter.

Brexit Secretary David Davis’s top parliamentary aide gave the most specific outline yet of the “red lines” Prime Minister Theresa May’s government will set in the looming talks to leave the European Union.

Technology News